Healthpeak Properties Inc
F:HC5
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Healthpeak Properties Inc
F:HC5
|
US |
|
Orange SA
PAR:ORA
|
FR |
|
Manulife Financial Corp
TSX:MFC
|
CA |
|
S
|
Sculptor Capital Management Inc
F:35OB
|
US |
|
Cronos Group Inc
TSX:CRON
|
CA |
|
Loncor Gold Inc
TSX:LN
|
CA |
|
S
|
Saha Pathanapibul PCL
SET:SPC
|
TH |
|
D
|
DC Healthcare Holdings Bhd
KLSE:DCHCARE
|
MY |
|
PCI Biotech Holding ASA
OSE:PCIB
|
NO |
|
Titan Medical Inc
TSX:TMD
|
CA |
|
PYC Therapeutics Ltd
ASX:PYC
|
AU |
Wall Street
Price Targets
HC5 Price Targets Summary
Healthpeak Properties Inc
According to Wall Street analysts, the average 1-year price target for HC5 is 16.39 EUR with a low forecast of 13.36 EUR and a high forecast of 25.17 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HC5's stock price target?
Price Target
16.39
EUR
According to Wall Street analysts, the average 1-year price target for HC5 is 16.39 EUR with a low forecast of 13.36 EUR and a high forecast of 25.17 EUR.
What is Healthpeak Properties Inc's Revenue forecast?
Projected CAGR
4%
For the last 14 years the compound annual growth rate for Healthpeak Properties Inc's revenue is 4%. The projected CAGR for the next 3 years is 4%.
What is Healthpeak Properties Inc's Operating Income forecast?
Projected CAGR
2%
For the last 14 years the compound annual growth rate for Healthpeak Properties Inc's operating income is -4%. The projected CAGR for the next 3 years is 2%.
What is Healthpeak Properties Inc's Net Income forecast?
Projected CAGR
36%
For the last 14 years the compound annual growth rate for Healthpeak Properties Inc's net income is -13%. The projected CAGR for the next 3 years is 36%.
